Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04897074 · ClinicalTrials.gov registry record · NA
Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents)
A NA study, sponsored by Akili Interactive Labs.
- Completed
- Registry status
- NA
- Development phase
- 165
- Enrollment target
NCT04897074 is a NA study that has completed, run by Akili Interactive Labs. The registered enrollment target is 165 participants.
The verdict
NCT04897074, a NA study, has completed, sponsored by Akili Interactive Labs.
- COMPLETED
- Registry status
- NA
- Development phase
- 165 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of videogame-like digital therapy on attentional functioning and symptoms in adolescents ages 13-17 diagnosed with ADHD
Interventions
- DEVICE AKL-T01
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2021-06-29 |
| Est. Completion | 2022-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04897074
The ClinicalTrials.gov registry entry for NCT04897074 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Akili Interactive Labs, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AKL-T01 is the first listed.
NCT04897074 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04897074 about?
NCT04897074 is a clinical study titled "Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents)". The purpose of this study is to evaluate the effects of videogame-like digital therapy on attentional functioning and symptoms in adolescents ages 13-17 diagnosed with ADHD
What is the current status of trial NCT04897074?
This trial is currently completed. It is a NA study. The enrollment target is 165 participants. The study started on 2021-06-29. Estimated completion is 2022-09-01.
What interventions are being tested in trial NCT04897074?
The interventions under investigation include: AKL-T01 (DEVICE).
Who is sponsoring clinical trial NCT04897074?
This trial is sponsored by Akili Interactive Labs, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.